Lars Rebien Sørensen
Chairman at Novo Nordisk Fonden
Net worth: 5 M $ as of 2024-11-29
Profile
Mr. Lars Rebien Sørensen is a Chairman at Novo Holdings A/S, a Chairman at Novo Holdings A/S, an Independent Director at Essity AB, an Independent Director at Thermo Fisher Scientific, Inc. and a Chairman at Novo Nordisk Fonden. He is on the Board of Directors at Essity AB, Thermo Fisher Scientific, Inc. and Jungbunzlauer AG. He has over 34 years of general management experience in the pharmaceutical industry. He joined the Novozymes A/S (then Novo Nordisk A/S, Enzymes Division) marketing team in 1982. Over the years he held various global positions across the Middle East and the United States. In 1994, he was appointed a member of the corporate management team and assumed responsibility for the Novozymes A/S healthcare business. In November 2000 he became President and CEO of Novo Nordisk A/S, a position he held until December 2016. He received an MSc in Forestry from the Copenhagen Royal Veterinary and Agricultural University in 1981 and a BSc in International Economics from Copenhagen Business School in 1983.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-05-21 | 9,233 ( 0.00% ) | 5 M $ | 2024-11-29 |
Latest news about Lars Rebien Sørensen
Lars Rebien Sørensen active positions
Companies | Position | Start |
---|---|---|
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Chairman | 2018-06-30 |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Chairman | 2018-06-30 |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages the assets and the wealth of the Novo Nordisk Foundation. | Chairman | 2018-06-30 |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Chairman | 2021-06-30 |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Chairman | 2021-06-30 |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Director/Board Member | 2024-04-07 |
Former positions of Lars Rebien Sørensen
Companies | Position | End |
---|---|---|
THERMO FISHER SCIENTIFIC INC. | Director/Board Member | 2024-05-21 |
Carlsberg Breweries A/S
Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Chairman | 2019-03-13 |
CARLSBERG A/S | Director/Board Member | 2019-03-12 |
░░░░ ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Lars Rebien Sørensen
University of Copenhagen | Graduate Degree |
Copenhagen Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 6 |
---|---|
ORSTED A/S | Utilities |
THERMO FISHER SCIENTIFIC INC. | Health Technology |
CARLSBERG A/S | Consumer Non-Durables |
NOVO NORDISK A/S | Health Technology |
SVENSKA CELLULOSA AKTIEBOLAGET SCA | Process Industries |
ESSITY AB | Consumer Non-Durables |
Private companies | 14 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Carlsberg Breweries A/S
Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Consumer Non-Durables |
Bertelsmann SE & Co. KGaA
Bertelsmann SE & Co. KGaA Movies/EntertainmentConsumer Services Bertelsmann SE & Co. KGaA engages in the provision of services related to media and education. It operates through the following segments: RTL Group, Penguin Random House, Gruner + Jahr, BMG, Arvato, Bertelsmann Printing Group, Bertelsmann Education Group, and Bertelsmann Investments. The RTL Group segment specializes in radio and television production. The Penguin Random House segment publishes books. The Gruner + Jahr segment focuses on magazines. The BMG segment engages in music production. The Arvato segment offers technology services. The Bertelsmann Printing Group segment unites the printing activities of the Bertelsmann Group. The Bertelsmann Education Group segment encompasses the overall education business. The Bertelsmann Investments segment comprises start-up and fund investments. The company was founded by Carl Bertelsmann in 1835 and is headquartered in Guetersloh, Germany. | Consumer Services |
Danmarks Nationalbank | Finance |
Bertelsmann Management SE
Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Commercial Services |
Novo Nordisk (Private Equity)
Novo Nordisk (Private Equity) Investment ManagersFinance Novo Nordisk A/S (CO: NOVO.B; NYSE: NVO), a Danish healthcare company which manufactures and markets pharmaceutical products and services worldwide, invests through their corporate venture fund NNBF-Novo Nordisk Biotech Fund (NNBF). Based in Bagsværd near Copenhagen, NNBF is a business unit within Novo Nordisk A/S, responsible for the company's venture capital activities. Investments are made on the books of Novo Nordisk A/S out of internal financial resources. NNBF is managed as an evergreen fund. | Finance |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Cameron Services AG
Cameron Services AG Food: Major DiversifiedConsumer Non-Durables Cameron Services AG produces natural and nature-identical biodegradable ingredients like citric acids and salts. It specializes in citric acid, xanthan gum, gluconates specialties, special salts and sweeteners for the food, beverage, pharmaceutical and cosmetic industries, as well as for various other industrial applications. The company was founded in 1867 by Ignatz Lederer and is headquartered in Basel, Switzerland. | Consumer Non-Durables |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages the assets and the wealth of the Novo Nordisk Foundation. | Finance |
Essity Germany GmbH
Essity Germany GmbH Household/Personal CareConsumer Non-Durables Part of Industrivärden AB, Essity Germany GmbH is the world's second largest supplier of consumer tissue, offering a range of products including toilet paper, kitchen rolls, facial tissues, handkerchiefs, and napkins. Essity Germany is based in Mannheim, DE, and Andreas Pier has been the CEO of the company since 2018. The German company provides practical advice for maintaining a clean and cozy home. | Consumer Non-Durables |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Lars Rebien Sørensen